Haemonetics | HAE - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
Avanos Medical USD 782.1M 3.9M 2026-03
Baxter International USD 6.04B 86M 2026-03
Becton, Dickinson and Co. USD 24.13B 1.15B 2026-03
Boston Scientific USD 25.86B 1.63B 2026-03
Cerus USD 64.22M 2.76M 2025-12
Cooper Companies USD 8.36B 124.7M 2025-12
Fresenius EUR 19.77B 1.14B 2025-12
Fresenius Medical Care EUR 14.2B 13.95B 2026-03
Globus Medical USD 4.73B 159.06M 2026-03
Haemonetics USD 796.32M 115.13M 2026-03
ICU Medical USD 2.11B 11.9M 2026-03
Intuitive Surgical USD 17.47B 349.5M 2026-03
Masimo USD 788.9M 67.7M 2026-03
Medtronic USD 48.99B 128M 2025-12
Merit Medical Systems USD 1.63B 42.42M 2026-03
Neogen USD 2.1B 2.09M 2025-12
OraSure Technologies USD 313.32M 27.5M 2026-03
Plus Therapeutics USD 11.96M 7.96M 2026-03
Quidel USD 1.85B 69.1M 2026-03
ResMed USD 6.49B 171.03M 2026-03
STAAR Surgical USD 352.37M 8.18M 2026-03
Steris USD 7.18B 29.1M 2026-03
Stryker USD 22.42B 635M 2025-12
Surmodics USD 111.31M 7.59M 2025-06
Teleflex USD 3.08B 40.33M 2026-03
Terumo JPY 1.58T 62.18B 2026-03
Thermo Fisher Scientific USD 51.93B 1.6B 2026-03
US Physical Therapy USD 468.98M 7.46M 2026-03
Zimmer Biomet Holdings USD 12.68B 16.1M 2026-03